APA (7th ed.) Citation

Xiaoyan Liu, Xiaoyan Liu, Yitian Lang, Yahui Liao, & Yizhun Zhu. (2021). Atezolizumab Plus Chemotherapy vs. Chemotherapy in Advanced or Metastatic Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Xiaoyan Liu, Xiaoyan Liu, Yitian Lang, Yahui Liao, and Yizhun Zhu. Atezolizumab Plus Chemotherapy Vs. Chemotherapy in Advanced or Metastatic Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Xiaoyan Liu, et al. Atezolizumab Plus Chemotherapy Vs. Chemotherapy in Advanced or Metastatic Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A., 2021.